Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma
- 24 October 2011
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 6 (12) , 2287-2293
Abstract
Malignant pleural mesothelioma (MPM) cells are characterized by chemoresistance associated with glutathione (GSH) metabolism. Ethacrynic acid (EA) is able to inhibit the detoxifying enzyme glutathione‐S‐transferase (GST), which catalyzes the conjugation between GSH and Pt‐based drugs. With the aim of obtaining active bifunctional drugs, a PtII complex containing two EA moieties as leaving groups, namely cis‐diamminobis(ethacrynato)platinum(II), was synthesized, characterized, and tested on four MPM cell lines. The resulting antiproliferative activity was compared with that elicited by the analogue PtIV complex, cis,cis,trans‐diamminodichloridobis(ethacrynato)platinum(IV) (ethacraplatin) and by the co‐administration of free EA and cisplatin. The PtII and PtIV bifunctional complexes showed poorer performance than the reference drug cisplatin alone or in combination with EA. After treatment, cellular GST activity remained consistently unchanged, while the GSH level increased.Keywords
This publication has 35 references indexed in Scilit:
- Studies of Glutathione Transferase P1‐1 Bound to a Platinum(IV)‐Based Anticancer Compound Reveal the Molecular Basis of Its ActivationChemistry – A European Journal, 2011
- A bifunctional organometallic ruthenium drug with multiple modes of inducing apoptosisJBIC Journal of Biological Inorganic Chemistry, 2011
- Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatinMolecular Cancer Therapeutics, 2008
- Rational Design of Platinum(IV) Compounds to Overcome Glutathione-S-Transferase Mediated Drug ResistanceJournal of the American Chemical Society, 2005
- Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug ResistanceChemical Reviews, 2003
- Platinum‐Sulfur Interactions Involved in Antitumor Drugs, Rescue Agents, and Biomolecules1999
- Immunoreactivity of pleural malignant mesotheliomas to glutathione S‐transferasesAPMIS, 1998
- GlutathioneS-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical studyJournal of Cancer Research and Clinical Oncology, 1996
- Contemporary Issues in ToxicologyToxicology and Applied Pharmacology, 1994
- Interactions of glutathione S-transferase-π with ethacrynic acid and its glutathione conjugateBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1993